The ALL Channel

Explore the latest updates, including expert interviews, features, podcasts and e-learning

The ALL Channel on VJHemOnc is supported by Pfizer. This supporter has no influence over the production of the content.

Welcome to The Acute Lymphoblastic Leukemia (ALL) Channel

Alongside a world-leading Editorial Board, VJHemOnc can provide all of the latest updates you need in ALL. Speaking directly with the experts at international congresses, The ALL Channel brings you video interviews, podcasts, roundtable discussions and more.

As well as therapy updates including CAR-T, antibody-drug conjugates and chemotherapy, The ALL Channel covers advances in transplantation, measurable residual disease (MRD), managing therapy toxicities, diagnosing ALL and more.

Conferences

SOHO 2022
EHA 2022
ASCO 2022
Tandem Meetings 2022
EBMT 2022
ASH 2021

Topics

Transplant
CAR-T & Cellular Therapy
MRD
Immuno-Oncology
Trial Updates
Treatment

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter